Merck, Schering-Plough Hit With False Marking Suit
Merck & Co. and subsidiary Schering-Plough Healthcare Products Inc. have been hit with a qui tam action alleging they falsely marked a Dr. Scholl's skin care cream with an expired patent...To view the full article, register now.
Already a subscriber? Click here to view full article